Issue 2-3/1998
Content (21 Articles)
In vitro and in vivo characterization of (+)-3-[11C]cyano-dizocilpine
S. Sihver, W. Sihver, Y. Andersson, T. Murata1, M. Bergström, H. Onoe, K. Matsumura, H. Tsukada, L. Oreland, B. Långström, Y. Watanabe
Effects of kynurenine metabolites on the electrocorticographic activity in the rat
I. Yokoi, Y. Nishijima, A. Uchida, H. Kabuto, N. Yamamoto, N. Ogawa
Effect of 5-fluoroindole-2-carboxylic acid (an antagonist of the NMDA receptor-associated glycine site) on the anticonvulsive activity of conventional antiepileptic drugs
R. Kamiński, B. Przywara, M. Gasior, Z. Kleinrok, S. J. Czuczwar
Melatonin inhibits oxytocin response to insulin-induced hypoglycemia, but not to angioten sin II in normal men
P. Chiodera, R. Volpi, L. Capretti, N. Giuliani, G. Caffarri, V. Coiro
Tolbutamide blocks postsynaptic but not presynaptic effects of adenosine on hippocampal CA1 neurones
H. Hosseinzadeh, T. W. Stone
Involvement of endogenous nitric oxide signalling system in brain muscarinic acetylcholine receptor activation
T. Borda, A. Genaro, L. Sterin-Borda, G. Cremaschi
In vivo occupation of dopamine D1, D2 and serotonin2A receptors by novel antipsychotic drug, SM-9018and its metabolite, in rat brain
Y. Takahashi, I. Kusumi, T. Ishikane, T. Koyama
5-Hydroxyindoles compounds and nitric oxide voltammetric detection in the rat brain: changes occurring throughout the sleep-wake cycle
R. Cespuglio, S. Burlet, H. Faradji-Prevautel
Retrospective application of a set of clinical diagnostic criteria for the diagnosis of multiple system atrophy
I. Litvan, V. Booth, G. K. Wenning, J. J. Bartko, C. G. Goetz, A. McKee, J. Jankovic, K. Jellinger, E. C. Lai, J. P. Brandel, M. Verny, K. Ray Chaudhuri, R. K. B. Pearce, Y. Agid
Bradykinesia and hypokinesia in Parkinson's disease: what's in a name?
J. J. van Hilten, A. A. van Eerd, E. A. H. Wagemans, H. A. M. Middelkoop, R. A. C. Roos
Sertraline induced parkinsonim. A case report and an in-vivo study of the effect of sertraline on dopamine metabolism
A. Di Rocco, T. Brannan, A. Prikhojan, M. D. Yahr
Plasma levels of R- and S-salsolinol are not increased in "de-novo" Parkinsonian patients
T. Müller, S. Sällström Baum, P. Häussermann, D. Woitalla, H. Rommelspacher, H. Przuntek, W. Kuhn
Pergolide: treatment of choice in Restless Legs Syndrome (RLS) and Nocturnal Myoclonus Syndrome (NMS). Longterm follow up on pergolide
J. Staedt, H. Hünerjäger, E. Rüther, G. Stoppe
BDNF and TrkB expression in intrastriatal ventral mesencephalic grafts in a rat model of Parkinson's disease
J. Sautter, M. Sabel, C. Sommer, S. Strecker, N. Weidner, W. H. Oertel, M. Kiessling
Neurotransmitter amino acids in cerebrospinal fluid of patients with Alzheimer's disease
F. J. Jiménez-Jiménez, J. A. Molina, P. Gómez, C. Vargas, F. de Bustos, J. Benito-León, A. Tallón-Barranco, M. Ortí-Pareja, T. Gasalla, J. Arenas
Cerebrospinal fluid levels of non-neurotransmitter amino acids in patients with Alzheimer's disease
J. A. Molina, F. J. Jiménez-Jiménez, C. Vargas, P. Gómez, F. de Bustos, M. Ortí-Pareja, A. Tallón-Barranco, J. Benito-León, J. Arenas, R. Enríquez-de-Salamanca
Abnormal amino acid metabolism in patients with early stage Alzheimer dementia
D. Fekkes, T. J. M. van der Cammen, C. P. M. van Loon, C. Verschoor, F. van Harskamp, I. de Koning, W. J. Schudel, L. Pepplinkhuizen
Antiglutamatergic therapy in Alzheimer's disease – effects of lamotrigine
S. Tekin, C. Aykut-Bingöl, T. Tanrıdağ, S. Aktan
Abnormal persistence of cerebellar serotonin-1A receptors in schizophrenia suggests failure to regress in neonates
P. Slater, C. A. Doyle, J. F. W. Deakin
Adult treatment with haloperidol increases dentate granule cell proliferation in the gerbil hippocampus
R. R. Dawirs, K. Hildebrandt, G. Teuchert-Noodt
Repeated trimipramine induces dopamine D2/D3 and α1-adrenergic up-regulation
J. Maj, Z. Rogóż, G. Skuza, W. Margas